MyoSense- Automated Muscle Hypertonicity Classification System


Phase N/A Results N/A

Trial Description

It is often difficult to quantify and distinguish aspects of abnormal muscle tone due to neurological injury. This makes it difficult to evaluate therapies that aim to reduce the effects of abnormal muscle tone. This research study will evaluate the feasibility of a clinician worn device to capture and quantify features of spasticity and dystonia.


Trial Design

  • Observation: Case-Only
  • Perspective: Cross-Sectional
  • Sampling: Non-Probability Sample

Trial Population

Sixty individuals, including individuals with and without abnormal muscle tone will be recruited for this study.


Type Measure Time Frame Safety Issue
Primary Correlation between clinician and device measured abnormal tone type. For each subject clinician and device data will be collected within a single session. Each session will occur over a maximum of two hours. Analysis of all of the subject data will be completed within 30 days of study completion. No